Tevogen stock rallies on expanded Microsoft AI collaboration

tupungato Tevogen Bio ( NASDAQ: TVGN ) stock jumped nearly 30% post-market after the company announced it has expanded its relationship with Microsoft ( NASDAQ: MSFT ) to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting. The Tevogen.AI initiative will.